We s t u d i e d two b r o t h e r s w i t h h e r e d i t a r y x
a n t h i n u r i a (xanthine oxidase d e f i c i e n c y ) and t h e i r f a m i l y members. The two b r o t h e r s had extremely low concentrations o f u r a t e b u t markedly h i g h c o n c e n t r a t i o n s o f xanthine and hypoxanthine i n plasma and u r i n e . Xanthine oxidase a c t i v i t i e s were v i r t u a l l y absent i n t h e duodenal mucosa. I n t h e i r parents (presumed o b l i g a t e heterozygotes), t h e a c t i v i t i e s o f xanthine oxidase were about h a l f t h a t o f normal subjects. Although plasma xanthine and hypoxanthine concentrations o f t h e parents were normal, u r i n a r y xanthine and hypoxanthine e x c r e t i o n s were s i g n i f i c a n t l y h i g h e r t h a n those o f normal s u b j e c t s (xanthine, f a t h e r 17.1 mg/g c r e a t i n i n e and mother 27.4 vs. normal c o n t r o l s 5.7 t o 11.0; hypoxanthine, f a t h e r 14.0 and mother 27.3 vs. c o n t r o l s 4.0 t o 8.4). S i m i l a r changes i n t h e m e t a b o l i t e c o n c e n t r a t i o n s were seen i n a t l e a s t 6 o t h e r re1 a t i v e s , suggesting t h e y were heterozygotes. This study i n d i c a t e s t h a t t h e presumed o b l i g a t e heterozygotes o f xanthine oxidase d e f i c i e n c y r e t a i n e d about h a l f normal enzyme a c t i v i t i e s causing t h e p a r t i a l metabolic blockage i n v i v o a t t h i s enzyme step. The dcT~/ara-CTP ratio seem to be one of very important factors in ara-C cytotoxicity. In confirmation of this hypothesis, we studied relations between cell growth and ratio of dc~~1ar-a-CTP in R.1.1. mice splenic cells, CCRF-CEM human T cell leukemic cells and ML-1 human myelogenous leukemic cells. (Method) Intracellular acidsoluble nucleotide were extracted with TCA, then neutralized with Freon and Amine. After periodate oxidation, deoxy-ribonucleotide were obtained. Intracellular ara-CTP and deoxy-ribonucleotide pools were analyzed by the HPLC method. (Result and Discussion) Growth of R.1.1. cells was inhibitted at concentration up to luM of ara-C. Intra-cellular dCTP and ara-CTP level in the R.1.1. cells exposure to luM of ara-C were 56.0 and 48.0pmo1/1 06cells, respectively, whereas exposure to lOuM of ara-C, intra-cellular dCTP and ara-CTP level were 44.0, 351 .Opmol/ 1 06cells, respectively. At the higher level of ara-CTP than o f dCTP, ara-C significantly effected on the growth of R.1.1. cells. Sarne relation was shown in CCRF-CEM cells and ML-1 cells. These data suggested that ara-C had significant effects on the growth of cells at the higher level of ara-CTP than of dCTP. So the dCTP/ara-CTP ratio is one of very important factors in ara-C cytotoxicity. 
RELATIONSHIP BETWEEN INTRAELLULAR ~CTP

--
Tatibana. Chlba University School of Medicine. Dept. of Biochemistry, Inohana, Chiba 280, Japan. Phosphoribosylpyrophosphate (PRPP), an important substrate in the synthesis of purine, pyrimidine and pyridlne nucleotides, is synthesized by the catalysis of PRPP synthetase. The enzyme from human erythrocytes exists as various associated forms and is sub2ect to complex regulation. However, the in situ regulation of PRPP synthesis is poorly understood. As an approach to the problem, we purified rat liver PRPP synthetase and partially characterized the complex physical nature of the enzyme. It was purified to a specific activity of 7.28 Umol/min/mg, the highest value so far reported for a mammalian enzyme, but still contained several components of 34 kDa, 38 kDa and 40 kDa in relative amounts of that order. In various usual chromatographies, these components were coeluted, suggesting that the heterogeneous aggregate is the native form of the enzyme. To identify the catalytic subunit, the enzyme was subjected to gel filtration on TSK GZOOOSW in 1 M MgC12, an agent to dissociate proteins. The enzyme appeared as a 68 kDa peak and the last quarter of the fractions contained only the 34 kDa species, wlth a definite catalytic activity. Other components in the aggregate appear to exert suppressive effects on the activity. Sequence analyses of N-terminal region and two tryptic peptides of the 34 kDa subunit, together wlth our cDNA cloning experiments (J.Biol. Chem., 262, 14867. 1987) . revealed that the 34 kDa component consists of two homologous isoforms (PRS I and 11).
EXERCISE-INDUCED ALTERATION OF ERYTIiROCYTE GLYCOLYSIS r l C
ASSOCIATiD WITH HYOGENIC HYPERURICEMIA
13
N o r i o Kono, Takao Shimizu, H i r o a k i Kiyokawa, Yuya Yamada, Naoko Hara, l k u o Mineo, Masanori Ka':achi, Hiromu Nakajima, Yan L i n Wang, Masamichi Kuwajima, and S e i i c h i r o T a r u i . Osaka U n i v e r s i t y Medical School, Second D e~a r t m e n t o f I n t e r n a l Medicine, Osaka, -~a~a n
Myogenic hyperuricpmia i s caused by increased p r o d u c t i o n o f u r i c a c i d secondar:~ t o enhanced release o f i n o s i n e and
hypoxanthine from e x e r c i s i n g muscles i n t o blood. This novel mechanism i s e v i d e n t i n glycogenosis types V I I (muscle phosphofructokinase d e f i c i e n c y ) , 111 (debranching enzyme d e f i c i e n c y ) , and V. I n t h i s study, we examined t h e e f f e c t o f muscular e x e r c i s e on t h e glyco1:rsis o f c i r c u l a t i n g e r y t h r o c y t e s i n glycogenosis types V I I and 111. The concentratinn o f e r y t h r o c y t e 2.3-bisphosphoglycerate, which had decreaspd because o f g e n e t i c p a r t i a l d e f i c i e n c y o f e r y t h r o c y t~ phosphofructnkinase, was f u r t h e r decreased a f t e r prnlonged bed r e s t i n p a t i e n t s w i t h type V I I . Ergometric e x e r c i s e r a p i d l y increased fructose-1,6-P2 , dihydroxyacetone-P p l u s glyceraldehyde-3-P, and 2,3-bisphosphog l y c e r a t e i n c i r c u l a t i n g e r y t h r o c y t e s . S i m i l a r changes werr observed a f t e r ~x e r c i s e i n p a t i p n t s w i t h type 111. The e x e r c i s einduced m e t a b o l i c a l t e r a t i o n of e r y t h r o c y t e s was reproduced i n v i t r o by i n c u b a t i n g normal e r y t h r o c y t e s i n the presence o f inosine. We conclude t h a t p h y s i c a l a c t i v i t y a f f e c t s g l y c o l y s i s i n e r y t h r o c y t e s i n glycogenosis types V I I and 111, and t h a t myogenic f a c t o r s i n c l u d i n g i n o s i n e are r e s p o l s i b l~ f o r t h i s change.
ISOLATION AND CIIARACTERIZATION OF HELA CELL MUTANTS RESISTANT TO AN ADENINE ANALOG 4-
76 CARBAMOYLIMIDAZOLIUM-5'-OLATE (CIO) . Siideki Kovama, Atsuko Tamura, Masa-aki Wachi, and Michio Matsubshi. Kihara Inst. Biol. Res., Yokohama City Univ., Yokohama, and Inst. Applied Microbiol., Univ. Tokyo, Tokyo, Japan.
It is known that CIO is metabolized into bredinin-5'-monophosphate (Brd-MP) by adenine phosphoribosyltransferase (APRT) and that this metabolite is a specific inhibitor of IMP dehydrogenase. We have reported that mouse cell mutants resistant to the cytotoxicity of CIO have lost the enzyme activity (Cancer Res., 42, 4210, 1982) . Recently, we isolated the same type of resistant mutants from mutagenized NeLa cells. In contrast, the HeLa cell mutants had a normal level of APRT and were cross-resistant to bredinin, a ribosylated form of CIO, but not to mycophenolic acid and virazole. These mutants showed a normal level of IMP dehydrogenase and the sensitivity to Brd-MP of the parental and mutant cell enzymes were similar. The mutants gradually reduced its resistance after passage without the p u g for more than 2 months. We also found that in 10 g supernatants prepared from the mutants there existed a 28 k protein by SDS polyacrylamide gel electrophoresis and its amount was proportional to the degree of the resistance. These results suggest that this protein should be involved in the resistance observed in the lleLa cell mutants.
